This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2sdf
From Proteopedia
|
SOLUTION NMR STRUCTURE OF STROMAL CELL-DERIVED FACTOR-1 (SDF-1), 30 STRUCTURES
Contents |
Overview
The three-dimensional structure of stromal cell-derived factor-1 (SDF-1), was determined by NMR spectroscopy. SDF-1 is a monomer with a disordered, N-terminal region (residues 1-8), and differs from other chemokines in the, packing of the hydrophobic core and surface charge distribution. Results, with analogs showed that the N-terminal eight residues formed an important, receptor binding site; however, only Lys-1 and Pro-2 were directly, involved in receptor activation. Modification to Lys-1 and/or Pro-2, resulted in loss of activity, but generated potent SDF-1 antagonists., Residues 12-17 of the loop region, which we term the RFFESH motif, unlike, the N-terminal region, were well defined in the SDF-1 structure. The, RFFESH formed a receptor binding site, which we propose to be an important, initial docking site of SDF-1 with its receptor. The ability of the SDF-1, analogs to block HIV-1 entry via CXCR4, which is a HIV-1 coreceptor for, the virus in addition to being the receptor for SDF-1, correlated with, their affinity for CXCR4. Activation of the receptor is not required for, HIV-1 inhibition.
Disease
Known diseases associated with this structure: AIDS, resistance to OMIM:[600835]
About this Structure
2SDF is a Single protein structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1., Crump MP, Gong JH, Loetscher P, Rajarathnam K, Amara A, Arenzana-Seisdedos F, Virelizier JL, Baggiolini M, Sykes BD, Clark-Lewis I, EMBO J. 1997 Dec 1;16(23):6996-7007. PMID:9384579
Page seeded by OCA on Mon Nov 12 23:38:03 2007
